27 results
8-K
EX-99.1
GMDAQ
Gamida Cell Ltd
27 Sep 23
Regulation FD Disclosure
4:43pm
and intensity of infusion reactions. In patients transplanted with OMISIRGE in clinical trials, 47% (55/117) patients had an infusion reaction of any
8-K
EX-99.1
g9lg2dj jrz0
17 Apr 23
Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval
5:29pm
10-Q
khc2qonq1p46lg
12 May 22
Quarterly report
7:42am
10-K
19ndsn 4s7aot37ee
24 Mar 22
Annual report
7:30am
6-K
EX-99.1
tbrvl
9 Mar 21
Gamida Cell Reports Full Year 2020 Financial Results and Provides Company Update
4:08pm
6-K
EX-99.2
w6bhol 9gk5y5wkw
9 Dec 20
Report of Foreign Private Issuer
3:37pm
424B4
gd7o7 0mk5xm1cumn3hq
28 Jun 19
Prospectus supplement with pricing info
3:51pm
F-1/A
4x58j
26 Jun 19
Registration statement (foreign) (amended)
12:00am
F-1
e4g4n5
24 Jun 19
Registration statement (foreign)
4:04pm
20-F
n7avyff4i877
25 Feb 19
Annual report (foreign)
5:08pm